COVID-19, which is caused by the SARS-CoV-2, has ravaged the world for the past 2 years.
Here, we review the current state of research into the disease with focus on its history …

The World Health Organization (WHO) has recently created a clinical case definition to
frame a condition of symptom persistence following a coronavirus disease 2019 (COVID …

We defined respiratory sarcopenia as a coexistence of respiratory muscle weakness and
decreased respiratory muscle mass. Although respiratory muscle function is indispensable …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection results in
multiorgan damage primarily mediated by viral infiltration via angiotensin-converting …

Objective To determine whether the addition of manual diaphragm release to an inspiratory
muscle training programme is more effective than inspiratory muscle training alone in …

COVID-19, the clinical syndrome produced by infection with SARS-CoV-2, can result in
multisystem organ dysfunction, including respiratory failure and hypercoagulability, which …

Severe acute respiratory syndrome coronavirus type 2 (SARS‐CoV‐2) causes coronavirus
disease 2019 (COVID‐19), characterised by high levels of inflammation and oxidative stress …

Objectives The post–COVID-19 condition (PCC) is a disabling syndrome affecting at least
5%–10% of subjects who survive COVID-19. SARS-CoV-2 mediated vagus nerve …

Post-acute COVID-19 is characterized by the persistence of dyspnea, but the
pathophysiology is unclear. We evaluated the prevalence of dyspnea during follow-up and …

Background Knowledge regarding the long-term impact of invasive mechanical ventilation
on the inspiratory muscles and functional outcomes in COVID-19 survivors is limited …